Press Information

Vencorex @ ACS 2014

On April 8-10 2014 Vencorex will attend the American Coating Show (ACS) at Atlanta, the largest coating event in US.

 

 Vencorex will present a wide range of isocyanates and solutions that facilitates the development of more environmentally-friendly technologies such as:

 

  • Tolonate™ aliphatic polyisocyanates crosslinkers for high-performance polyurethane coatings & adhesives, which offer exceptional durability and non-yellowing properties upon ageing, with high solids, low VOC options
  • Based on a unique patented technology, the Easaqua™ grades are self-emulsifiable polyisocyanates, used as crosslinkers of effective environmentally-friendly waterborne polyurethane alternatives to conventional solvent-based coatings.
  • HDI and IPDI isocyanate monomers, essential building blocks for polyurethane dispersions (PUD)

 

“Although Vencorex is a company with a new name, it has a long history of being one of the top polyurethane suppliers in the world.  We are excited to be at the ACS and to show our current and future customers the innovations and new technologies we have developed.  Exhibitions such as this show are still one of the most important communication channels to promote our products” said Shane Steelman Marketing and Sales Director North America for Vencorex

  Visit us @ booth n°221

PDF

Vencorex increases prices on Aliphatic isocyanates.

 Effective March 1st 2014, or as existing contracts permit, Vencorex will increase prices on HDI (Hexamethylene Di-Isocyanate) and derivatives range (Tolonate™ and Easaqua™).

 Prices will be increased by 5% to 10%.

 Prices are being increased due to current market situation and higher costs of raw materials.

For further information, please contact:

Per Erik Velin, Marketing & Sales Global Director for HDI & derivatives- Phone: +33 4 26 22 38 20

Per-erik.velin@vencorex.com

PDF Doc

 

 

Vencorex announces its long term strategic ambition on development of performance isocyanates

Vencorex presents today its long term strategic ambition. This strategy is based on focusing its activities toward specialty isocyanates. (HDI, IPDI, derivatives and new products).

Vencorex objective is to strengthen its worldwide position in Aliphatic Isocyanates business. (HDI, IPDI, Tolonate™ & Easaqua™ grades and new products).

 To achieve this long term ambition, Vencorex plans to enhance its footprint on production capabilities, commercial activities and R&D innovation towards the following configuration:

 Tolonate™ production facilities in 3 main continents ready to serve global market. Vencorex already has these at Pont De Claix, France and Freeport, TX USA, with an additional facility being implemented in Thailand, starting in 2015.

  • Pont De Claix will continue to be the production hub of HDI and IPDI monomers with significantly larger capacity and expansion in new products.
  • The global Sales & Marketing organization will be strengthened to capture growth opportunities and better serve international customers.
  • R&D capabilities in France to be further developed to support this strategy through the innovation of new products and applications.

With all these initiatives, Vencorex will therefore implement several industrial projects with the objective to sustain its position as a leading global partner for specialty isocyanates in the coming years.

 Vencorex strategic ambition is supported by both shareholders: PTTGC and Perstorp.

 For further information, please contact:

Vencorex holding: Sandrine Nabet, Market Communications Manager – Phone: +33 6 80 48 18 47

communication@vencorex.com

 PDF. Doc

 

 

 

Vencorex expands its Tolonate™ HDI derivatives capacity into Asia and strengthen its global position

As a key supplier of isocyanates, Vencorex is expanding its global capacity for Tolonate™ HDI derivatives by establishing a new production unit in Thailand. The new plant will be ready to serve the Asian market in 2015.

“We want to strengthen our global position, and our presence in Asia will be a significant stepping stone, among others” says CEO Magnus Lanner. “This new asset in Asia, with an annual capacity of 12,000 tons per year and our own state-of-the-art technology, will serve this expansion, helping the industry in Asia to provide very high quality offerings and technology.  Thailand is a strategic location and will provide Vencorex with a competitive advantage in the region.

 “Asia is fast growing and this new capacity will allow us to effectively participate in this rapidly expanding market.  We will improve our level of service through these dedicated resources within the region.  The new plant in Thailand will provide us with an industrial footprint for HDI and derivatives: in addition the markets served by Pont-de-Claix in France and Freeport in the USA”, says Sutin Chamulitrat, Vice President, Marketing & Sales.

 With this investment in Aliphatic Isocyanates derivatives production in Asia, Vencorex will have global facilities on 3 continents. Vencorex has strong ambition to be your core partner as a solution provider in this business.

 

 For further information, please contact:

Vencorex holding: Sandrine Nabet, Market Communications Manager – Phone: +33 6 80 48 18 47

communication@vencorex.com

Press Release Vencorex expands its capacity in Asia